Savara (SVRA) Preferred Stock Liabilities (2014 - 2016)
Savara's (SVRA) quarterly Preferred Stock Liabilities came in at $43.9 million in Q4 2016, up 2.04% year-on-year from $43.0 million in Q1 2016, and up 2.04% on a QoQ basis from $43.0 million in Q4 2015.
Savara (SVRA) Preferred Stock Liabilities (2014 - 2016) Analysis & Trends
Savara (SVRA) has 3 years of Preferred Stock Liabilities data on file, last reported at $43.9 million in Q4 2016.
- On a quarterly basis, Preferred Stock Liabilities rose 2.04% year-over-year to $43.9 million in Q4 2016; TTM through Dec 2016 was $43.9 million, a 2.04% increase from a year earlier, with the FY2016 full-year figure at $43.9 million, up 2.04% from the prior year.
- Preferred Stock Liabilities for Q4 2016 stood at $43.9 million, up from $43.0 million in the prior quarter.
- Over the last five years, Preferred Stock Liabilities for SVRA reached as high as $43.9 million in Q4 2016 and fell as low as $20.3 million in Q4 2014.
- Historically, Preferred Stock Liabilities has averaged $35.7 million across 3 years, with a median of $43.0 million in 2015.
- Across the five-year window, Preferred Stock Liabilities jumped 112.05% in 2015 and increased 2.04% in 2016, its largest moves.
- Year by year, Preferred Stock Liabilities stood at $20.3 million in 2014, then jumped by 112.05% to $43.0 million in 2015, then climbed by 2.04% to $43.9 million in 2016.
- Per Business Quant data, the three most recent Preferred Stock Liabilities figures were $43.9 million in Q4 2016, $43.0 million in Q4 2015, and $20.3 million in Q4 2014.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Savara | 1.24 Bn | 1.24 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 43.86 Mn |
| Dec 31, 2015 | 42.99 Mn |
| Dec 31, 2014 | 20.27 Mn |